Skip to main content

Table 2 Characteristics of participants and non-participants in the DanACo cohort and the LiKO-15 and DiaKO-19 studies

From: The Danish Aging and Cognition (DanACo) cohort

 

DanACo cohort

LiKO-15 study

DiaKO-19 study

Participants

Non-participants

P-value

Participants

Non-participants

P-value

Participants

Non-participants

P-value

Total, n(%)

5340 (14.3)

32,104* (85.7)

 

2611 (13.1)

17,277 (86.9)

 

2729 (12.8)

18,632 (87.2)

 

Birth year, Mean(SD)

1954.1 (3.2)

1954.6 (3.2)

 < 0.001

1954.4 (3.2)

1955.0 (3.2)

 < 0.001

1953.9 (3.1)

1954.3 (3.1)

 < 0.001

Conscription board examination

 Age, Mean(SD)

20.4 (2.1)

20.0 (1.8)

 < 0.001

20.3 (2.0)

19.8 (1.7)

 < 0.001

20.5 (2.2)

20.0 (1.9)

 < 0.001

 BPP-score, Mean(SD)

46.6 (9.5)

39.8 (11.3)

 < 0.001

46.2 (9.8)

38.9 (11.4)

 < 0.001

47.0 (9.3)

40.6 (11.1)

 < 0.001

 Educational level, n(%)

  

 < 0.001

  

 < 0.001

  

 < 0.001

 Low

1492 (28.0)

15,965 (49.8)

 

782 (30.0)

9017 (52.2)

 

710 (26.0)

8904 (47.9)

 

 Medium

1784 (33.5)

9118 (28.4)

 

871 (33.5)

4856 (28.1)

 

913 (33.5)

5319 (28.6)

 

 High

2053 (38.5)

6976 (21.8)

 

950 (36.5)

3392 (19.7)

 

1103 (40.5)

4370 (23.5)

 

 Height, Mean(SD)

179.4 (6.7)

178.5 (7.8)

 < 0.001

179.3 (7.1)

178.5 (8.6)

 < 0.001

179.5 (6.4)

178.5 (6.6)

 < 0.001

 Weight, Mean(SD)

69.6 (9.2)

69.1 (11.5)

 < 0.001

69.0 (8.9)

68.5 (12.6)

0.012

70.3 (9.5)

69.5 (10.0)

 < 0.001

Information from hospital registers

 Admission to a psychiatric ward, n(%)

112501 (21.1)

8814 (27.5)

 < 0.001

863 (33.1)

8068 (46.7)

 < 0.001

262 (9.6)

3007 (16.1)

 < 0.001

 Charlson Comorbidity Index score, Mean(SD)

1.0 (1.7)

1.3 (2.0)

 < 0.001

0.9 (1.6)

1.3 (2.1)

 < 0.001

1.1 (1.7)

1.3 (1.9)

 < 0.001

  1. Abbreviations: DanACo Danish Aging and Cognition cohort, LiKO-15 Lifestyle and Cognition Follow-up study 2015, DiaKO-19 Diabetes and Cognition Follow-up study 2019, SD Standard deviation, BPP Børge Prien’s Prøve (the military intelligence test)
  2. *3,805 non-participants from the LiKO-15 study were also invited to the DiaKO-19 study. Consequently, the total number of non-participants in the DanACo cohort (n = 37,444) is equal to the combined number of non-participants from the LiKO-15 and DiaKO-19 studies (35,909) minus the 3,805 participants that were invited twice